Table 2. Characteristics of multiple myeloma patients.

Pat No	sex [f/m]	age* [years]	PC** [%]	PC*** [%]	Ig type [g/L]	Stage Durie/Salmon	WBC [x109/L]	Hb [g/dL]	PLT [x109/L]	β2-microglobulin [mg/L]	BM cytogenetics	time of sampling
1	m	53	90	42	IgG lambda [83.7]	III	3.44	9.5	148	8.11	46,XY	diagnosis
2	m	84	15	14	lambda [32.9]	II	7.58	11.8	335	21.1	46,XY	diagnosis
3	f	68	95	34	IgA kappa [33.10]	II	3.21	8.3	98	9.52	complex	diagnosis
4	m	48	80	77	IgG kappa [23.4]	III	6.11	9.9	169	3.73	not done	diagnosis
5	m	85	70	11	IgA kappa [24.4]	III	4.73	8.6	294	4.23	46,XY	diagnosis
6	f	69	70	18	IgA lambda [57.2]	I	8.16	9.3	338	9.81	47,XX,+17	diagnosis
7	f	71	80	21-22	IgA kappa [19.3]	II	7.16	10.4	420	5.52	complex	diagnosis
8	f	54	90	>90	IgG kappa [56.3]	I	3.73	8.9	38	5.79	complex	relapse

Pat No, patient number; m, male; f, female; PC, plasma cells; WBC, white blood count; Hb, hemoglobin; PLT, platelets; BM, bone marrow; n.t., not tested. *Age at the time of BM sampling (in most cases BM was obtained at diagnosis). **Percentage of plasma cells (of all nucleated BM cells) in immunohistochemical examinations in BM sections. ***Percentage of plasma cells (of all nucleated BM cells) in BM smears